83 related articles for article (PubMed ID: 2914169)
1. [Generation of blood anticoagulant and fibrinolytic activity after intravenous administration of protein C-a in rats].
Kogan AE; Strukova SM
Biull Eksp Biol Med; 1989 Jan; 107(1):3-5. PubMed ID: 2914169
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis.
van Veen SQ; Levi M; van Vliet AK; Florquin S; van Gulik TM; Boermeester MA
Crit Care Med; 2006 Nov; 34(11):2799-805. PubMed ID: 17006359
[TBL] [Abstract][Full Text] [Related]
4. Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.
Colucci M; Stassen JM; Collen D
J Clin Invest; 1984 Jul; 74(1):200-4. PubMed ID: 6547456
[TBL] [Abstract][Full Text] [Related]
5. Protein C.
Esmon CT
Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
[TBL] [Abstract][Full Text] [Related]
6. [Participation of protein C in reaction of the anti-coagulant system to intravenous administration of thrombin and thromboplastin to rats].
Kogan AE; Strukova SM; Tara AA; Aaviksaar AA
Vopr Med Khim; 1992; 38(1):48-50. PubMed ID: 1441296
[TBL] [Abstract][Full Text] [Related]
7. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
8. [Activation of the anticoagulation system following intravenous administration of beta-thrombin].
Strukova SM; Umarova BA; Semenova OA; Liapina LA; Kudriashov BA
Fiziol Zh SSSR Im I M Sechenova; 1979 May; 65(5):702-6. PubMed ID: 456683
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
10. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
Umarova BA; Strukova SM; Kudriashov BA
Vopr Med Khim; 1984; 30(2):95-100. PubMed ID: 6540008
[TBL] [Abstract][Full Text] [Related]
11. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
12. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
Pastorova VE
Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
[TBL] [Abstract][Full Text] [Related]
13. [The anticoagulant system following intravenous administration of factor XIII and thromboplastin].
Liapina LA; Ul'ianov AM; Zhitnikova ES
Fiziol Zh SSSR Im I M Sechenova; 1976 Aug; 62(8):1166-70. PubMed ID: 992139
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis in the rat after short-term aspirin therapy.
Housholder GT; Moorrees LL
J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
[TBL] [Abstract][Full Text] [Related]
15. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
16. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic effect of protein C activator from a snake venom].
Strukova SM; Kogan AE; Tara AA; Aaviksaar AA
Vopr Med Khim; 1989; 35(5):115-9. PubMed ID: 2617927
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
19. Hemostasis development in the lamb fetus and neonate.
Moalic P; Gruel Y; Foloppe P; Delahousse B; Leclerc MH; Leroy J
Am J Vet Res; 1989 Jan; 50(1):59-63. PubMed ID: 2919828
[TBL] [Abstract][Full Text] [Related]
20. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
